ZymeDeal Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Grant
  • Investors
  • 4

ZymeDeal General Information

Description

Developer of a polymer for food preservation. The company synthesizes a modified polymer which helps preserve and extend the shelf life of packaged goods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Specialty Chemicals
Primary Office
  • London
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ZymeDeal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Jul-2015 Completed Startup
3. Accelerator/Incubator 01-Jan-2015 Completed Startup
2. Grant $5K Completed Startup
1. Grant 01-Oct-2014 $4.07K Completed Startup
To view ZymeDeal’s complete valuation and funding history, request access »

ZymeDeal Executive Team (4)

Name Title Board Seat Contact Info
Annie Dou Co-Founder
Evelyn Liu Co-Founder
Qiyun Zhong Co-Founder
Sijia Yu Co-Founder
To view ZymeDeal’s complete executive team members history, request access »

ZymeDeal Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZymeDeal Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
China UK Challenge Other 000 0000 000000 0
Imperial Create Lab Accelerator/Incubator 000 0000 000000 0
Imperial College London University 000 0000 000000 0
EIT Climate-KIC Accelerator/Incubator Minority 000 0000 000000 0
To view ZymeDeal’s complete investors history, request access »